Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.39 -0.01 (-0.71%)
As of: Oct 21, 2026 · 3:59 PM EDT

Actinium Pharmaceuticals (ATNM) EV to EBITDA (2026)

Updated

Actinium Pharmaceuticals' EV to EBITDA was -0.58 in Q2 2026.

Analysis

Actinium Pharmaceuticals (ATNM) EV to EBITDA (2026) Analysis & Trends

On a trailing twelve-month basis, Actinium Pharmaceuticals' EV to EBITDA was -15.25 through Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Actinium Pharmaceuticals 43.69 Mn -136.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.58
API Access

Actinium Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ATNM&period=max&api_key=YOUR_API_KEY